Magnova 500 mg/62.5 mg Injection

By Magnova

Rx

1 Injection in a Vial

Composition icon

Composition

Cefepime(500mg) + Tazobactum(62.5mg)

Manufacturer - Lupin Ltd icon

Manufacturer - Lupin Ltd

Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after icon

Expires on or after

April, 2026

About Magnova 500 mg/62.5 mg Injection

Magnova 500 mg/62.5 mg Injection is a combination of two antibiotics used to treat various bacterial infections. It works by stopping the growth of microorganisms, helping the body fight against the infection. It is important to follow the dosage instructions carefully and only take this medicine under the supervision of a healthcare professional.

Do not skip any scheduled appointments for taking Magnova 500 mg/62.5 mg Injection. Even if you start to feel better, it is crucial to complete the full course of the medicine as prescribed. This will help ensure that the infection is fully treated and prevent it from recurring.

Like any medication, Magnova 500 mg/62.5 mg Injection may cause side effects. Common side effects include nausea, vomiting, diarrhea, and rashes. You may also experience redness, swelling, or pain at the injection site, which usually resolves on its own. If any side effects worsen or if you experience signs of an allergic reaction such as rashes, itching, or difficulty breathing, seek medical help immediately.

Before starting treatment with Magnova 500 mg/62.5 mg Injection, inform your doctor about any other medications you are taking for other health conditions. Pregnant or breastfeeding women should consult with their doctor before using this medication. It is advisable to avoid alcohol while taking this medicine to prevent excessive drowsiness. While it generally does not affect your ability to drive, refrain from driving if you feel excessively sleepy or dizzy after taking the injection.


Benefits

Magnova 500 mg/62.5 mg Injection offers several benefits in treating bacterial infections. It is a combination of two powerful medicines, Cefepime and Tazobactum, that work in tandem to combat and eliminate the harmful bacteria responsible for infections. Cefepime acts by inhibiting the growth of bacteria, while Tazobactum works to reduce resistance and enhance the effectiveness of Cefepime. This combination makes Scud XP Injection highly effective in treating a wide range of bacterial infections.

One of the key benefits of Magnova 500 mg/62.5 mg Injection is its fast-acting nature. Patients often experience improvement in their condition within just a few days of starting the treatment. This quick response can help alleviate symptoms and accelerate the healing process, making the patient feel better sooner.

Moreover, it is important to note that even when the symptoms subside, it is crucial to complete the full course of Magnova 500 mg/62.5 mg Injection as prescribed by the healthcare provider. This ensures that all bacteria are completely eradicated from the body, minimizing the risk of them developing resistance to the medication.

Overall, Magnova 500 mg/62.5 mg Injection is a reliable and potent treatment option for bacterial infections due to its dual-action formula, rapid effectiveness, and ability to prevent bacterial resistance.


How to use the Magnova 500 mg/62.5 mg Injection

To use Magnova 500 mg/62.5 mg Injection, it is important to remember that you should always have a doctor or nurse administer this medicine to you. It is not recommended to self-administer this injection. Your healthcare provider will determine the correct dosage and frequency based on your specific condition and needs. They will inject the medicine into a muscle or a vein as directed. Make sure to follow their instructions carefully and do not try to inject yourself. If you have any questions or concerns about how to use Magnova 500 mg/62.5 mg Injection, do not hesitate to ask your healthcare provider for clarification. It is important to adhere to the recommended guidelines for safe and effective use of this medicine.


Uses of Magnova 500 mg/62.5 mg Injection

The Magnova 500 mg/62.5 mg Injection is primarily used to treat bacterial infections in the body. This includes infections caused by various types of bacteria. The injection contains specific medications that are effective in targeting and eliminating these harmful bacteria. It is important to follow the prescribed dosage and duration of the treatment as advised by a healthcare professional to ensure the best results in combating bacterial infections.


What conditions Magnova 500 mg/62.5 mg Injection treats?

Magnova 500 mg/62.5 mg Injection is used to treat various bacterial infections. The combination of Cefepime and Tazobactum in this medicine works to kill the bacteria causing the infections. It is essential to complete the full course of medication as prescribed, even if symptoms improve, to ensure all bacteria are eliminated. Common side effects like nausea, vomiting, and diarrhea may occur. If side effects worsen or allergic reactions such as rashes or swelling develop, seek medical help. Pregnant or breastfeeding women should consult their doctor before taking this medicine.


Should you consult a doctor?

If you experience any allergic reaction such as rashes, itching, swelling, or shortness of breath after using Magnova 500 mg/62.5 mg Injection, seek immediate medical assistance. Additionally, if any common side effects like nausea, vomiting, diarrhea, or injection site redness worsen, consult your doctor promptly. It is crucial to contact your healthcare provider if you notice any unusual symptoms while taking this medication.

Furthermore, pregnant or breastfeeding individuals should talk to their doctors before using Scud XP Injection. Remember to inform your healthcare provider about any other medications you are taking for underlying health conditions. If you have concerns about the side effects or notice persistent issues, seek medical advice promptly.

Always adhere to scheduled appointments and complete the full course of this antibiotic, even if symptoms improve. Avoid alcohol consumption while using this medication to prevent adverse reactions. If you encounter any problems or have questions about the treatment, contact your doctor for proper guidance.


Side effects of Magnova 500 mg/62.5 mg Injection

The Magnova 500 mg/62.5 mg Injection may cause certain side effects, although most of them do not need medical attention and tend to resolve as your body gets used to the medication. However, it is important to consult your doctor if any side effects persist or if they are concerning to you. Some possible side effects of this injection include diarrhea, increased white blood cell count called eosinophils, inflammation at the injection site known as phlebitis, skin rash, elevated liver enzymes, and a positive Coombs test result. If you experience any of these side effects, it is best to seek guidance from your healthcare provider.


Safety advice

scroll

liver

Magnova 500 mg/62.5 mg Injection is considered safe for individuals with liver disease. The available data indicates that adjusting the dosage of Magnova 500 mg/62.5 mg Injection may not be necessary for patients with liver issues. However, it is always recommended to consult with your doctor before using this medication, especially if you have any liver-related concerns.

scroll

kidney

Magnova 500 mg/62.5 mg Injection should be used carefully in individuals with kidney disease. Adjusting the dosage may be necessary. Please seek advice from your healthcare provider.

scroll

alcohol

Caution is advised when drinking alcohol while using Magnova 500 mg/62.5 mg Injection. It is recommended to consult your doctor for more information.

scroll

driving

Caution Magnova 500 mg/62.5 mg Injection may temporarily blur your vision after use. Avoid driving until your vision has fully cleared.

scroll

pregnancy

Magnova 500 mg/62.5 mg Injection is generally safe during pregnancy based on animal studies with low adverse effects to the baby, but human data is limited.

scroll

breastfeeding

During breastfeeding, it is considered safe to use Magnova 500 mg/62.5 mg Injection. Studies show that the drug does not pass into breastmilk in harmful amounts.


Consumption warning before consuming Magnova 500 mg/62.5 mg Injection

Before consuming Magnova 500 mg/62.5 mg Injection, it is crucial to follow these guidelines for your safety. This medication is a combination of two antibiotics used to treat bacterial infections. It should only be administered under the supervision of a healthcare professional. Ensure you do not miss any scheduled appointments for taking this medicine and complete the full course as prescribed, even if you start feeling better.

Common side effects may include nausea, vomiting, diarrhea, and rashes. Additionally, you might experience redness, swelling, or pain at the injection site, which should subside over time. If any side effects worsen, seek immediate medical advice. In case of allergic reactions such as rashes, itching, swelling, or breathing difficulties, seek urgent medical help.

Inform your doctor about any other medications you are currently taking and consult them if you are pregnant or breastfeeding. Avoid alcohol as it can enhance drowsiness when combined with this medication. While it generally does not affect your driving ability, refrain from driving if you feel excessively drowsy or dizzy.


What if you forgot to take Magnova 500 mg/62.5 mg Injection?

If you forget to take a dose of Magnova 500 mg/62.5 mg Injection, it is important to consult your doctor promptly. Missing a dose of this medication may impact its effectiveness in treating your condition. Your doctor will be able to provide guidance on the best course of action to take in case of a missed dose. It is crucial to follow your doctor's instructions closely to ensure that you are receiving the full benefits of Magnova 500 mg/62.5 mg Injection. If you have any concerns or questions about missed doses, do not hesitate to reach out for medical advice.


Related lab tests

Related Lab Tests:

When using Magnova 500 mg/62.5 mg Injection, it is important to monitor certain lab tests to ensure the medication is being effective and safe for the patient. One crucial lab test is the Complete Blood Count (CBC), which helps in evaluating overall health and detecting a variety of disorders such as anemia, infection, and leukemia. The CBC includes measurements of red blood cells, white blood cells, and platelets, providing valuable information about the patient's blood cell levels.

Additionally, a Peripheral Smear Examination may be recommended while using Magnova 500 mg/62.5 mg Injection. This test involves examining a sample of blood under a microscope to assess the size, shape, and structure of different blood cells. It can provide further insights into various blood disorders and conditions like infections, anemias, and leukemia.

By monitoring these related lab tests regularly, healthcare providers can closely monitor the impact of Magnova 500 mg/62.5 mg Injection on the patient's blood cell counts and overall health. It is essential to follow the recommended testing schedule and discuss any concerns or abnormalities with a healthcare professional promptly.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI INFECTIVES
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

301.25

Inclusive of all taxes

Content verified by

chevron-right

Dr. Abdullah Khan

MBBS - General Medicine

Last update on 01-Oct-2024